Elizabeth L. Hougen

2020

In 2020, Elizabeth L. Hougen earned a total compensation of $4.3M as Executive Vice President, Finance and Chief Financial Officer at Ionis Pharmaceuticals, a 25% increase compared to previous year.

Compensation breakdown

Bonus$298,734
Option Awards$1,815,765
Salary$499,555
Stock Awards$1,663,208
Other$63,838
Total$4,341,100

Hougen received $1.8M in option awards, accounting for 42% of the total pay in 2020.

Hougen also received $298.7K in bonus, $499.6K in salary, $1.7M in stock awards and $63.8K in other compensation.

Rankings

In 2020, Elizabeth L. Hougen's compensation ranked 2,607th out of 13,090 executives tracked by ExecPay. In other words, Hougen earned more than 80.1% of executives.

ClassificationRankingPercentile
All
2,607
out of 13,090
80th
Division
Manufacturing
1,001
out of 5,620
82nd
Major group
Chemicals And Allied Products
369
out of 2,253
84th
Industry group
Drugs
317
out of 1,953
84th
Industry
Pharmaceutical Preparations
232
out of 1,458
84th

Pay ratio

Elizabeth L. Hougen's Pay$4,341,100
Median Employee's Pay$352,641
Pay Ratio

12

to 1

In 2020, the annual total compensation of Elizabeth L. Hougen was $4,341,100.

The annual total compensation of the median employee at Ionis Pharmaceuticals was $352,641.

The ratio of Elizabeth L. Hougen's pay to the pay of median employee was therefore 12 to one.

Source: SEC filing on April 23, 2021.

Hougen's colleagues

We found four more compensation records of executives who worked with Elizabeth L. Hougen at Ionis Pharmaceuticals in 2020.

2020

Brett Monia

Ionis Pharmaceuticals

Chief Executive Officer

2020

Stanley Crooke

Ionis Pharmaceuticals

Chairman

2020

Richard Geary

Ionis Pharmaceuticals

Executive Vice President, Chief Development Officer

2020

Patrick O'Neil

Ionis Pharmaceuticals

General Counsel

News

You may also like